Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Dr Agarwals Eye Hospital Ltd. Share Price
Day's Range
Day's Range
Low
₹4,960.00
High
₹5,175.50
Price Summary
| Previous Close | ₹5,084.00 |
|---|---|
| Day's Range | ₹4,960.00 - ₹5,175.50 |
| Open | ₹4,960.00 |
| 52 Week Range | ₹4,600.00 - ₹6,059.70 |
| Volume | 657 |
| Market Cap | ₹0.00 |
| Previous Close | ₹5,099.90 |
|---|---|
| Day's Range | ₹4,975.75 - ₹5,161.25 |
| Open | ₹5,049.00 |
| 52 Week Range | ₹4,231.00 - ₹6,392.00 |
| Volume | 215 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 33.40 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.14 |
| Price/Earning (TTM) | 34.57 |
| TTM EPS (₹) | 145.05 |
| P/E Ratio | 34.85 |
| Book Value(₹) | 7.00 |
| PAT Margin (%) | 13.76 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 33.26 |
| Trade Value ( ₹ in Lacs) | 10.96 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.14 |
| Price/Earning (TTM) | 34.57 |
| TTM EPS (₹) | 145.05 |
| P/E Ratio | 34.85 |
| Book Value(₹) | 7.00 |
| PAT Margin (%) | 13.76 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 33.26 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 3971.5 | 998.3 |
| Expenses | N/A | N/A |
| PBT | 707.0 | 186.0 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 546.5 | 159.9 |
About Dr Agarwals Eye Hospital Ltd.
| Founded | 1994 |
|---|---|
| Managing Director | Amar Agarwal |
| NSE Symbol | DRAGARWQ |
Latest News
Dr Agarwals Eye Hospital informs about compliances-certificate
Artemis Medicare Service informs about newspaper advertisement
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Artemis Medicare Service has informed that it enclosed the copy of the advertisement published in the newspapers, The Financial Express (English National Daily Newspaper- all editions) and The Jansatta (Hindi National Daily Newspaper- Delhi edition) on July 15, 2026, regarding the public notice for the opening of a Special Window for Transfer and Dematerialisation of Physical Securities.
The above information is a part of company’s filings submitted to BSE.
Biocon informs about AGM
Vivo Bio Tech informs about press release
Nureca informs about certificate
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, Nureca has informed that it enclosed a copy of the Certificate received from Alankit Assignments, Registrar and Share Transfer Agent (‘RTA’) of the Company for the quarter ended on June 30, 2026.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Dr Agarwals Eye Hospital Ltd. is ₹5,084.00 as of 2026-07-15.
The market capitalisation of Dr Agarwals Eye Hospital Ltd. is ₹2,423.25 as of 2026-07-14.
The 1-year return of Dr Agarwals Eye Hospital Ltd. is % as of .
The P/E ratio of Dr Agarwals Eye Hospital Ltd. is 34.85 as of 2026-07-15.
The 52-week high and low of Dr Agarwals Eye Hospital Ltd. are ₹6,059.70 and ₹4,600.00, respectively, as of 2026-07-15.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
